Medtronic’s Infuse Bone Growth product was originally marketed as an innovative way to perform spinal fusion surgeries by using a genetically engineered protein to stimulate bone growth in the spine. However, nearly 85% of procedures using Infuse are now off-label – which is causing concern about who’s liable for its related injuries. Who’s Responsible for […]